CVC and Temasek to buy $2 billion generic drugs firm Alvogen
European private equity fund CVC and Singaporean sovereign wealth fund Temasek are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairman and chief executive said.
Jun 22, 2015, 13:37 PM IST